Centogene CentoXome Gold, CentoXome Platinum
Centogene has released two clinical exome sequencing patient-parent trio tests, CentoXome Gold and CentoXome Platinum. The tests include Sanger confirmation and a medical report, using the company's proprietary CentoMD variant database, and promise reportable variants in more than 60 percent of cases. CentoXome Gold, which covers 95 percent of targets with greater than 10-fold coverage, has a turnaround time of 45 to 60 days and a price of €1,980 ($2,180). CentoXome Platinum covers 95 percent of targets with greater than 20-fold coverage. The test, which is aimed at urgent cases, including prenatal testing, has a turnaround time of less than 15 days and a price of €3,975.